Raphael Pharmaceutical Inc. Total Liabilities and Equity
Raphael Pharmaceutical Inc. (RAPH) had Total Liabilities and Equity of $7.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet
us-gaap:LiabilitiesAndStockholdersEquity · last filed 2026-08-14
- 2026-06-30: Liabilities and Equity $7.00K.
- 2026-03-31: Liabilities and Equity $3.00K.
- 2025-12-31: Liabilities and Equity $53.00K.
- 2025-09-30: Liabilities and Equity $7.00K.
| Period end | Liabilities and Equity | Liabilities and Equity as first filed |
|---|---|---|
| 2026-06-30 | $7.00K 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $3.00K 10-Q · filed 2026-05-14 | |
| 2025-12-31 | $53.00K 10-Q · filed 2026-08-14 | |
| 2025-09-30 | $7.00K 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $30.00K 10-Q · filed 2025-08-13 | |
| 2025-03-31 | $93.00K 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $27.00K 10-K · filed 2026-03-31 | |
| 2024-09-30 | $51.00K 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $128.00K 10-Q · filed 2024-08-12 | |
| 2024-03-31 | $353.00K 10-Q · filed 2024-05-15 | |
| 2023-12-31 | $239.00K 10-K · filed 2025-03-31 | $339.00K 10-K · filed 2024-03-28 |
| 2023-09-30 | $403.00K 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $119.00K 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $150.00K 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $333.00K 10-K · filed 2024-03-28 | |
| 2022-09-30 | $121.00K 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $196.00K 10-Q · filed 2022-08-12 | |
| 2022-03-31 | $180.00K 10-Q · filed 2022-05-16 | |
| 2021-12-31 | $422.00K 10-K/A · filed 2023-05-25 | |
| 2021-09-30 | $62.00K 10-Q · filed 2021-11-16 | |
| 2020-12-31 | $323.00K 10-K · filed 2022-03-30 |